201 related articles for article (PubMed ID: 31043525)
21. Comparison of vaccine subpopulation selection, viral loads, vaccine virus persistence in trachea and cloaca, and mucosal antibody responses after vaccination with two different Arkansas Delmarva Poultry Industry -derived infectious bronchitis virus vaccines.
Ndegwa EN; Toro H; van Santen VL
Avian Dis; 2014 Mar; 58(1):102-10. PubMed ID: 24758121
[TBL] [Abstract][Full Text] [Related]
22. Phylogenetic analysis of infectious bronchitis virus circulating in southern China in 2016-2017 and evaluation of an attenuated strain as a vaccine candidate.
Chen L; Xiang B; Hong Y; Li Q; Du H; Lin Q; Liao M; Ren T; Xu C
Arch Virol; 2021 Jan; 166(1):73-81. PubMed ID: 33067648
[TBL] [Abstract][Full Text] [Related]
23. Attenuation mechanism of virulent infectious bronchitis virus strain with QX genotype by continuous passage in chicken embryos.
Huo YF; Huang QH; Lu M; Wu JQ; Lin SQ; Zhu F; Zhang XM; Huang YY; Yang SH; Xu CT
Vaccine; 2016 Jan; 34(1):83-9. PubMed ID: 26611202
[TBL] [Abstract][Full Text] [Related]
24. Development of a recombinant Newcastle disease virus-vectored vaccine for infectious bronchitis virus variant strains circulating in Egypt.
Abozeid HH; Paldurai A; Varghese BP; Khattar SK; Afifi MA; Zouelfakkar S; El-Deeb AH; El-Kady MF; Samal SK
Vet Res; 2019 Feb; 50(1):12. PubMed ID: 30744668
[TBL] [Abstract][Full Text] [Related]
25. Cross-protective immune responses elicited by a Korean variant of infectious bronchitis virus.
Kim BY; Lee DH; Jang JH; Lim TH; Choi SW; Youn HN; Park JK; Lee JB; Park SY; Choi IS; Song CS
Avian Dis; 2013 Sep; 57(3):667-70. PubMed ID: 24283135
[TBL] [Abstract][Full Text] [Related]
26. Recombinant infectious bronchitis virus (IBV) H120 vaccine strain expressing the hemagglutinin-neuraminidase (HN) protein of Newcastle disease virus (NDV) protects chickens against IBV and NDV challenge.
Yang X; Zhou Y; Li J; Fu L; Ji G; Zeng F; Zhou L; Gao W; Wang H
Arch Virol; 2016 May; 161(5):1209-16. PubMed ID: 26873815
[TBL] [Abstract][Full Text] [Related]
27. Kidney Cell-Adapted Infectious Bronchitis Virus Arkansas Delmarva Poultry Industry Vaccine Confers Effective Protection Against Challenge.
Ghetas AM; van Santen VL; Joiner K; Toro H
Avian Dis; 2016 Jun; 60(2):418-23. PubMed ID: 27309281
[TBL] [Abstract][Full Text] [Related]
28. Comparative Protective Efficacies of Novel Avian Paramyxovirus-Vectored Vaccines against Virulent Infectious Bronchitis Virus in Chickens.
Shirvani E; Samal SK
Viruses; 2020 Jun; 12(7):. PubMed ID: 32605292
[TBL] [Abstract][Full Text] [Related]
29. Development and immunogenic potentials of chitosan-saponin encapsulated DNA vaccine against avian infectious bronchitis coronavirus.
Bande F; Arshad SS; Bejo MH; Omar AR; Moeini H; Khadkodaei S; Wei TS; Keong YS; Abba Y; Anka IA
Microb Pathog; 2020 Dec; 149():104560. PubMed ID: 33068733
[TBL] [Abstract][Full Text] [Related]
30. A reverse genetics system for avian coronavirus infectious bronchitis virus based on targeted RNA recombination.
van Beurden SJ; Berends AJ; Krämer-Kühl A; Spekreijse D; Chénard G; Philipp HC; Mundt E; Rottier PJM; Verheije MH
Virol J; 2017 Jun; 14(1):109. PubMed ID: 28606144
[TBL] [Abstract][Full Text] [Related]
31. Biological and molecular characterization of ArkGA: A novel Arkansas serotype vaccine that is highly attenuated, efficacious, and protective against homologous challenge.
Albanese GA; Lee DH; Cheng IN; Hilt DA; Jackwood MW; Jordan BJ
Vaccine; 2018 Oct; 36(41):6077-6086. PubMed ID: 30197283
[TBL] [Abstract][Full Text] [Related]
32. S1 of distinct IBV population expressed from recombinant adenovirus confers protection against challenge.
Toro H; Zhang JF; Gallardo RA; van Santen VL; van Ginkel FW; Joiner KS; Breedlove C
Avian Dis; 2014 Jun; 58(2):211-5. PubMed ID: 25055623
[TBL] [Abstract][Full Text] [Related]
33. Enhanced Protection by Recombinant Newcastle Disease Virus Expressing Infectious Bronchitis Virus Spike Ectodomain and Chicken Granulocyte-Macrophage Colony-Stimulating Factor.
Khalid Z; He L; Yu Q; Breedlove C; Joiner K; Toro H
Avian Dis; 2021 Sep; 65(3):364-372. PubMed ID: 34427409
[TBL] [Abstract][Full Text] [Related]
34. Attenuated live infectious bronchitis virus QX vaccine disseminates slowly to target organs distant from the site of inoculation.
Laconi A; Weerts EAWS; Bloodgood JCG; Deniz Marrero JP; Berends AJ; Cocciolo G; de Wit JJ; Verheije MH
Vaccine; 2020 Feb; 38(6):1486-1493. PubMed ID: 31822427
[TBL] [Abstract][Full Text] [Related]
35. Cross-Protection by Infectious Bronchitis Viruses Under Controlled Experimental Conditions.
Toro H; van Santen VL; Ghetas AM; Joiner KS
Avian Dis; 2015 Dec; 59(4):532-6. PubMed ID: 26629628
[TBL] [Abstract][Full Text] [Related]
36. Infectious Bronchitis Virus Population Structure Defines Immune Response and Protection.
Zegpi RA; Joiner KS; van Santen VL; Toro H
Avian Dis; 2020 Mar; 64(1):60-68. PubMed ID: 32267126
[TBL] [Abstract][Full Text] [Related]
37. Identification of IBV QX vaccine markers : Should vaccine acceptance by authorities require similar identifications for all live IBV vaccines?
Listorti V; Laconi A; Catelli E; Cecchinato M; Lupini C; Naylor CJ
Vaccine; 2017 Oct; 35(42):5531-5534. PubMed ID: 28917538
[TBL] [Abstract][Full Text] [Related]
38. Recombinant infectious bronchitis viruses expressing heterologous S1 subunits: potential for a new generation of vaccines that replicate in Vero cells.
Bickerton E; Dowgier G; Britton P
J Gen Virol; 2018 Dec; 99(12):1681-1685. PubMed ID: 30355423
[TBL] [Abstract][Full Text] [Related]
39. Avian coronavirus infectious bronchitis attenuated live vaccines undergo selection of subpopulations and mutations following vaccination.
McKinley ET; Hilt DA; Jackwood MW
Vaccine; 2008 Mar; 26(10):1274-84. PubMed ID: 18262691
[TBL] [Abstract][Full Text] [Related]
40. Rapid development and evaluation of a live-attenuated QX-like infectious bronchitis virus vaccine.
Zhang Y; Huang S; Zeng Y; Xue C; Cao Y
Vaccine; 2018 Jul; 36(29):4245-4254. PubMed ID: 29891352
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
